Fingerprint
Dive into the research topics of 'Pharmacokinetics and Exposure–Response Analyses of Daratumumab in Combination Therapy Regimens for Patients with Multiple Myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pharmacokinetics and Exposure–Response Analyses of Daratumumab in Combination Therapy Regimens for Patients with Multiple Myeloma
Xu Steven Xu*, Meletios A. Dimopoulos, Pieter Sonneveld, P. Joy Ho, Andrew Belch, Merav Leiba, Marcelo Capra, David Gomez, Eva Medvedova, Shinsuke Iida, Chang Ki Min, Jordan Schecter, Richard Jansson, Liping Zhang, Yu Nien Sun, Pamela L. Clemens
*Corresponding author for this work
- Johnson & Johnson
- National and Kapodistrian University of Athens
- Erasmus University Rotterdam
- Royal Prince Alfred Hospital
- Cross Cancer Institute
- Assuta Ashdod Hospital
- Hospital Mãe de Deus
- Universidad Autonoma de Nuevo Leon
- Oregon Health and Science University
- Nagoya City University
- The Catholic University of Korea
Research output: Contribution to journal › Article › peer-review
23
Scopus
citations